Women comprise over 50% of global population but represent only 30% of research authorships; cardiovascular and reproductive health research historically excluded female subjects entirely. Latin American indigenous and Afro-descendant women face worse health outcomes due to inadequate medical attention and research gaps in HIV prevention and cancer detection strategies.
El País
· Dec 25, 2023
· health
· 5 min read
High
Sourcing: Verified
Patriarchal Medicine: How Male-Centered Research Fails Women's Health
At least 1.5 million preventable deaths among women annually due to gaps in cancer prevention and early detection; indigenous and Afro-descendant women experience shortened life expectancy from inadequate healthcare attention.
◉
Health & Medicine
2812 related articles
FDA approves Wegovy for heart disease prevention, expanding blockbuste…
infobae · 99% match
El ARN mensajero abre camino a vacunas contra 30 enfermedades infeccio…
infobae · 90% match
Weight-Loss Drugs Show Promise in Reducing Alcohol Cravings, But Clini…
infobae · 90% match
WHO endorses GLP-1 weight-loss drugs, issues first clinical guidance a…
El Tiempo · 90% match
Ozempic: Riesgos crecientes por uso estético sin supervisión médica
Medio digital El Zorro Nortino · 90% match
Related Coverage
El Mostrador · Aug 23
Guía de alimentos a limitar para proteger la salud cardiovascular
Expertos recomiendan limitar embutidos, bebidas azucaradas y ultraprocesados para reducir riesgos cardiovasculares. La a…
OkDiario · Aug 23 La boca seca no es una molestia menor: cuándo consultar al médicoLa xerostomía o boca seca es un problema infradiagnosticado que afecta a una de cada tres personas mayores de 60 años, f…
Segre.com · Aug 23 Programa pionero de ejercicio monitorizado mejora la salud cardiopulmonar en LleidaUn programa pionero en Lleida utiliza ejercicio físico monitorizado y análisis de 30 variables metabólicas para mejorar …
El País · Aug 23 No habrá una vacuna contra el cáncer, sino una distinta para cada paciente y tumorModerna y MSD avanzan hacia la aprobación de una vacuna de ARN mensajero personalizada contra el melanoma que reduce un …
Bias & Framing
⚖
Article uses strong ideological framing ('patriarchal medicine') to present gender disparities in medical research as systemic oppression, with limited acknowledgment of methodological or practical counterarguments.
Bias Direction
left
Confidence
HIGH
Problem-solution framing with moral urgency; positions gender disparities in medical research as evidence of patriarchal system rather than exploring multifactorial causes (regulatory history, biological complexity, funding patterns, etc.)
patriarchal medicine
patriarchal approach
hostile world for women
sexist inequality
machista perspective
preventable deaths
deficient or null attention
Historical context on why male-centered research occurred (e.g., reproductive safety concerns post-thalidomide)
Progress made in recent decades toward inclusion
Counterarguments or nuance on biological sex differences in research design
Perspectives from medical researchers on implementation challenges
Data on current inclusion rates in clinical trials
Discussion of intersecting factors beyond gender (socioeconomic, geographic access)
Geopolitical Impact
🌎
Article addresses systemic gender bias in biomedical research excluding women from clinical trials, causing preventable deaths—primarily a public health and social justice issue with limited direct geopolitical implications.
Escalation Risk
low
Confidence
HIGH
Latin America
Spain
Mexico
Indigenous and Afro-descendant communities globally
Highlights institutional power imbalances within scientific/medical establishments favoring male-centered research paradigms. Reflects broader gender equity debates in global health governance but does not directly alter state-level power relations or international alliances.
Echoes historical exclusion of women from medical research (e.g., Tuskegee-era practices), now framed through contemporary gender equity lens rather than geopolitical competition.
Economic Lens
📈
Systematic exclusion of women from clinical trials and biomedical research causes preventable deaths and healthcare disparities, with disproportionate impact on indigenous and Afro-descendant women in Latin America.
Market Signal
mixed
Confidence
HIGH
Healthcare and pharmaceuticals
Medical research and biotechnology
Insurance and health services
Public health systems
Medical device manufacturing
Women face higher mortality rates, delayed diagnoses, and inadequate treatment protocols due to male-centered drug development and clinical guidelines. Healthcare costs increase through preventable complications and emergency interventions. Vulnerable populations (indigenous and Afro-descendant women) experience worst outcomes.
Regulatory bodies may mandate gender-inclusive clinical trial requirements; healthcare systems may need to revise diagnostic protocols; pharmaceutical companies face pressure to conduct sex-specific efficacy studies; potential litigation regarding inadequate treatment standards; increased public health spending on preventive care and early detection programs.